US5359035A
(en)
*
|
1985-12-21 |
1994-10-25 |
Hoechst Aktiengesellschaft |
Bifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF)
|
WO1991001146A1
(en)
*
|
1989-07-14 |
1991-02-07 |
Praxis Biologics, Inc. |
Cytokine and hormone carriers for conjugate vaccines
|
US6541610B1
(en)
*
|
1989-09-05 |
2003-04-01 |
Immunex Corporation |
Fusion proteins comprising tumor necrosis factor receptor
|
DK0417563T3
(da)
|
1989-09-12 |
2000-11-06 |
Hoffmann La Roche |
TNF-bindende proteiner
|
NZ236819A
(en)
*
|
1990-02-03 |
1993-07-27 |
Max Planck Gesellschaft |
Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions
|
CA2089553C
(en)
*
|
1990-08-29 |
2000-06-27 |
Paul Schendel |
Multidomain hematopoiesis stimulators
|
JPH05502463A
(ja)
*
|
1990-09-28 |
1993-04-28 |
オーソ・フアーマシユーチカル・コーポレーシヨン |
ハイブリツド成長因子
|
US5650150A
(en)
*
|
1990-11-09 |
1997-07-22 |
Gillies; Stephen D. |
Recombinant antibody cytokine fusion proteins
|
US5420027A
(en)
*
|
1991-01-10 |
1995-05-30 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the expression of biologically active fusion proteins comprising a eukaryotic cytochrome P450 fused to a reductase in bacteria
|
US5525491A
(en)
*
|
1991-02-27 |
1996-06-11 |
Creative Biomolecules, Inc. |
Serine-rich peptide linkers
|
US5409825A
(en)
*
|
1991-04-09 |
1995-04-25 |
Indiana University Foundation |
Expansion of human hematopoietic progenitor cells in a liquid medium
|
US5744361A
(en)
*
|
1991-04-09 |
1998-04-28 |
Indiana University |
Expansion of human hematopoietic progenitor cells in a liquid medium
|
US5199942A
(en)
*
|
1991-06-07 |
1993-04-06 |
Immunex Corporation |
Method for improving autologous transplantation
|
US6028177A
(en)
*
|
1991-10-04 |
2000-02-22 |
Washington University |
Methods of detecting single-chain forms of the glycoprotein hormone quartet
|
US5716805A
(en)
*
|
1991-10-25 |
1998-02-10 |
Immunex Corporation |
Methods of preparing soluble, oligomeric proteins
|
US5262522A
(en)
*
|
1991-11-22 |
1993-11-16 |
Immunex Corporation |
Receptor for oncostatin M and leukemia inhibitory factor
|
FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
US6174666B1
(en)
|
1992-03-27 |
2001-01-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of eliminating inhibitory/instability regions from mRNA
|
CA2133326C
(en)
*
|
1992-03-30 |
2005-03-01 |
Craig A. Smith |
Fusion proteins comprising tumor necrosis factor receptor
|
ES2198414T3
(es)
*
|
1992-10-23 |
2004-02-01 |
Immunex Corporation |
Procedimientos para preparar proteinas oligomericas solubles.
|
US5463029A
(en)
*
|
1992-11-23 |
1995-10-31 |
Immunex Corporation |
Purification of fusion proteins comprising GM-CSF and IL-3
|
US5738849A
(en)
*
|
1992-11-24 |
1998-04-14 |
G. D. Searle & Co. |
Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
|
US6057133A
(en)
*
|
1992-11-24 |
2000-05-02 |
G. D. Searle |
Multivariant human IL-3 fusion proteins and their recombinant production
|
US7091319B1
(en)
|
1992-11-24 |
2006-08-15 |
Bauer S Christopher |
IL-3 variant hematopoiesis fusion protein
|
US6413509B1
(en)
|
1992-11-24 |
2002-07-02 |
S. Christopher Bauer |
Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
|
US6361977B1
(en)
|
1992-11-24 |
2002-03-26 |
S. Christopher Bauer |
Methods of using multivariant IL-3 hematopoiesis fusion protein
|
US5538863A
(en)
*
|
1993-07-01 |
1996-07-23 |
Immunex Corporation |
Expression system comprising mutant yeast strain and expression vector encoding synthetic signal peptide
|
WO1995013089A1
(en)
*
|
1993-11-10 |
1995-05-18 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Compositions and method for stimulating antibody release by b lymphocytes
|
US20050059149A1
(en)
*
|
1993-11-22 |
2005-03-17 |
Bauer S. Christopher |
Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins
|
US8241900B1
(en)
|
1994-01-03 |
2012-08-14 |
Genentech, Inc. |
mpl ligand
|
US8192955B1
(en)
|
1994-01-03 |
2012-06-05 |
Genentech, Inc. |
Nucleic acids encoding MPL ligand (thrombopoietin), variants, and fragments thereof
|
US8357513B1
(en)
|
1994-01-03 |
2013-01-22 |
Genentech, Inc. |
Nucleic acids encoding mpl ligand (thrombopoietin) and fragments thereof
|
US8147844B1
(en)
|
1994-01-03 |
2012-04-03 |
Genentech, Inc. |
Mpl ligand (thrombopoietin), nucleic acids encoding such, and methods of treatment using mpl ligand
|
CA2139385C
(en)
*
|
1994-02-04 |
2001-12-25 |
Gottfried Alber |
Products containing g-csf and tnf binding protein
|
US8278099B1
(en)
|
1994-02-15 |
2012-10-02 |
Genentech, Inc. |
Monoclonal antibody to human thrombopoietin
|
US5627264A
(en)
*
|
1994-03-03 |
1997-05-06 |
Alexion Pharmaceuticals, Inc. |
Chimeric complement inhibitor proteins
|
US5783672A
(en)
*
|
1994-05-26 |
1998-07-21 |
Immunex Corporation |
Receptor for oncostatin M
|
US6048837A
(en)
*
|
1994-08-17 |
2000-04-11 |
The Rockefeller University |
OB polypeptides as modulators of body weight
|
US6429290B1
(en)
|
1994-08-17 |
2002-08-06 |
The Rockefeller University |
OB polypeptides, modified forms and derivatives
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
US6471956B1
(en)
|
1994-08-17 |
2002-10-29 |
The Rockefeller University |
Ob polypeptides, modified forms and compositions thereto
|
US6350730B1
(en)
|
1994-08-17 |
2002-02-26 |
The Rockefeller University |
OB polypeptides and modified forms as modulators of body weight
|
US6124448A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockfeller University |
Nucleic acid primers and probes for the mammalian OB gene
|
US6001968A
(en)
|
1994-08-17 |
1999-12-14 |
The Rockefeller University |
OB polypeptides, modified forms and compositions
|
NZ311982A
(en)
|
1995-06-29 |
1999-08-30 |
Immunex Corp |
Tnf related apoptosis inducing ligand (trail), a method for producing them and associated antibodies
|
RO120579B1
(ro)
|
1995-10-04 |
2006-04-28 |
Immunex Corporation |
Utilizarea ligandului flt3
|
US20080286228A1
(en)
*
|
1995-10-20 |
2008-11-20 |
Tarantolo Stefano R |
Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
|
AU703120B2
(en)
*
|
1995-10-20 |
1999-03-18 |
University Of Nebraska Board Of Regents |
Composition and methods for enhancing immune responses mediated by antigen-presenting cells
|
US20030040467A1
(en)
*
|
1998-06-15 |
2003-02-27 |
Mary Ann Pelleymounter |
Ig/ob fusions and uses thereof.
|
US6936439B2
(en)
*
|
1995-11-22 |
2005-08-30 |
Amgen Inc. |
OB fusion protein compositions and methods
|
GB9526733D0
(en)
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US5846780A
(en)
*
|
1996-10-04 |
1998-12-08 |
Millennium Pharmaceuticals, Inc. |
Murine RATH gene
|
US6020142A
(en)
*
|
1996-10-04 |
2000-02-01 |
Millennium Pharmaceuticals, Inc. |
Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders
|
US6884419B1
(en)
*
|
1996-12-23 |
2005-04-26 |
Kyowa Hakko Kogyo, Co., Ltd. |
hG-CSF fusion polypeptide having c-mpl activity, DNA coding for same and methods of treating anemia using same
|
US6384203B1
(en)
|
1999-05-12 |
2002-05-07 |
Immunex Corporation |
Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
|
KR100220645B1
(ko)
*
|
1997-07-04 |
1999-09-15 |
구광시 |
벤젠유도체의 제조방법
|
US6242570B1
(en)
|
1997-07-10 |
2001-06-05 |
Beth Israel Deaconess Medical Center |
Production and use of recombinant protein multimers with increased biological activity
|
US6187564B1
(en)
|
1997-07-10 |
2001-02-13 |
Beth Israel Deaconess Medical Center |
DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
|
US6165476A
(en)
*
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
WO1999015548A2
(en)
*
|
1997-09-25 |
1999-04-01 |
Academisch Ziekenhuis Bij De Universiteit Van Amsterdam |
Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof
|
EP1489100B1
(en)
|
1997-12-08 |
2016-06-15 |
Merck Patent GmbH |
Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
|
US6291661B1
(en)
*
|
1998-07-02 |
2001-09-18 |
Immunex Corporation |
flt3-L mutants and method of use
|
US7264809B1
(en)
|
1998-10-16 |
2007-09-04 |
Immunex Corporation |
Methods of inhibiting platelet activation and recruitment
|
CA2345382A1
(en)
*
|
1998-10-16 |
2000-04-27 |
Immunex Corporation |
Inhibitors of platelet activation and recruitment
|
JP2002537769A
(ja)
|
1999-02-26 |
2002-11-12 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
ヒトエンドカインαおよび使用方法
|
EE200100597A
(et)
*
|
1999-05-13 |
2003-02-17 |
American Cyanamid Company |
Antigeenne kompositsioon kombinatsioonis adjuvantidega ning meetod selle toimetõhususe suurendamiseks
|
ES2317843T3
(es)
*
|
1999-07-13 |
2009-05-01 |
Bolder Biotechnology, Inc. |
Proteinas de fusion de eritropoyetina-inmunoglobulina.
|
SK782002A3
(en)
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
US7067110B1
(en)
|
1999-07-21 |
2006-06-27 |
Emd Lexigen Research Center Corp. |
Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
ES2256027T3
(es)
|
1999-08-09 |
2006-07-16 |
Emd Lexigen Research Center Corp. |
Complejos de anticuerpos que contienen multiples citoquinas.
|
WO2001036489A2
(en)
|
1999-11-12 |
2001-05-25 |
Merck Patent Gmbh |
Erythropoietin forms with improved properties
|
WO2001045730A2
(en)
|
1999-12-20 |
2001-06-28 |
Immunex Corporation |
Tweak receptor
|
MXPA02007733A
(es)
|
2000-02-11 |
2004-09-10 |
Merck Patent Gmbh |
Mejoramiento de la vida media circulante de proteinas de fusion basadas en anticuerpos.
|
US6946134B1
(en)
|
2000-04-12 |
2005-09-20 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
JP2003530847A
(ja)
*
|
2000-04-12 |
2003-10-21 |
ヒューマン ゲノム サイエンシズ インコーポレイテッド |
アルブミン融合タンパク質
|
US7138501B2
(en)
|
2000-06-16 |
2006-11-21 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind BLyS
|
CN1270775C
(zh)
|
2000-06-29 |
2006-08-23 |
默克专利有限公司 |
通过与免疫细胞因子摄入促进剂联合治疗来增强抗体-细胞因子融合蛋白介导的免疫反应
|
US6652854B2
(en)
|
2000-08-08 |
2003-11-25 |
Immunex Corporation |
Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L
|
EA004744B1
(ru)
*
|
2000-11-10 |
2004-08-26 |
Уайт Холдингз Корпорейшн |
Комбинированные композиции адъювантов
|
EP1683865A3
(en)
|
2001-02-02 |
2006-10-25 |
Eli Lilly & Company |
Mammalian proteins and in particular CD200
|
JP2005503116A
(ja)
|
2001-02-09 |
2005-02-03 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
ヒトgタンパク質ケモカインレセプター(ccr5)hdgnr10
|
PL206701B1
(pl)
|
2001-03-07 |
2010-09-30 |
Merck Patent Gmbh |
Immunoglobulinowe białko fuzyjne, kodujący je kwas nukleinowy, replikujący wektor ekspresji zawierający taki kwas nukleinowy, eukariotyczna komórka gospodarza zawierająca taki wektor ekspresji oraz sposób zwiększania ekspresji takiego białka fuzyjnego
|
US6992174B2
(en)
|
2001-03-30 |
2006-01-31 |
Emd Lexigen Research Center Corp. |
Reducing the immunogenicity of fusion proteins
|
US20060084794A1
(en)
*
|
2001-04-12 |
2006-04-20 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US20050244931A1
(en)
*
|
2001-04-12 |
2005-11-03 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US7507413B2
(en)
|
2001-04-12 |
2009-03-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US20050054051A1
(en)
*
|
2001-04-12 |
2005-03-10 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
EP1385864B1
(en)
|
2001-04-13 |
2010-06-09 |
Human Genome Sciences, Inc. |
Anti-VEGF-2 antibodies
|
JP4309662B2
(ja)
|
2001-05-03 |
2009-08-05 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
腫瘍特異的組換え抗体およびその使用
|
US20070015144A9
(en)
*
|
2001-05-25 |
2007-01-18 |
Genset, S.A. |
Human cDNAs and proteins and uses thereof
|
WO2002097033A2
(en)
|
2001-05-25 |
2002-12-05 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
US6867189B2
(en)
*
|
2001-07-26 |
2005-03-15 |
Genset S.A. |
Use of adipsin/complement factor D in the treatment of metabolic related disorders
|
KR100453877B1
(ko)
*
|
2001-07-26 |
2004-10-20 |
메덱스젠 주식회사 |
연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 TNFR/Fc 융합 단백질, 상기 단백질을 코딩하는 DNA, 상기 DNA를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
|
AU2002332041A1
(en)
*
|
2001-10-05 |
2003-04-22 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
RU2312677C9
(ru)
|
2001-12-04 |
2008-03-27 |
Мерк Патент Гмбх |
Иммуноцитокины с модулированной селективностью
|
US7858297B2
(en)
*
|
2001-12-18 |
2010-12-28 |
Centre National De La Recherche Scientifique Cnrs |
Chemokine-binding protein and methods of use
|
CA2471777A1
(en)
*
|
2001-12-18 |
2003-06-26 |
Endocube Sas |
Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
|
JP5424521B2
(ja)
|
2001-12-21 |
2014-02-26 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
アルブミン融合タンパク質
|
US20080194481A1
(en)
|
2001-12-21 |
2008-08-14 |
Human Genome Sciences, Inc. |
Albumin Fusion Proteins
|
WO2005003296A2
(en)
|
2003-01-22 |
2005-01-13 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
JP2005523001A
(ja)
*
|
2002-02-11 |
2005-08-04 |
ザイモジェネティクス,インコーポレイティド |
二量体増殖因子を調製するための材料と方法
|
CA2480052A1
(en)
*
|
2002-04-01 |
2003-10-16 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to gmad
|
CU23229A1
(es)
*
|
2002-05-10 |
2007-09-26 |
Ct Ingenieria Genetica Biotech |
ANTAGONISTA QUIMéRICO ANTH1
|
KR100418329B1
(ko)
*
|
2002-07-26 |
2004-02-14 |
메덱스젠 주식회사 |
직렬 연쇄체를 갖는 면역접합체
|
CA2818693C
(en)
|
2002-08-12 |
2016-05-17 |
Jennerex, Inc. |
Methods and compositions concerning poxviruses and cancer
|
PL211180B1
(pl)
|
2002-12-17 |
2012-04-30 |
Merck Patent Gmbh |
Białko fuzyjne typu przeciwciało-IL2, wektor zawierający sekwencję kwasów nukleinowych kodujących takie białko, kompozycja farmaceutyczna zawierająca takie białko fuzyjne oraz jego zastosowania do wytwarzania leków
|
WO2004065551A2
(en)
*
|
2003-01-21 |
2004-08-05 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel acyl coenzyme a, monoacylglycerol acyltransferase-3 (mgat3), and uses thereof
|
CA2533512C
(en)
|
2003-07-25 |
2013-06-11 |
Amgen Inc. |
Antagonists and agonists of ldcam and methods of use
|
EP1710255A4
(en)
*
|
2003-12-12 |
2008-09-24 |
Chugai Pharmaceutical Co Ltd |
MODIFIED ANTIBODIES RECOGNIZING A TRIMER OR LARGER RECEPTOR
|
DK1697399T3
(en)
|
2003-12-12 |
2017-03-06 |
Government Of The United States Of America As Repr By The Secr Of The Dept Of Health And Human Servi |
Human cytotoxic t lymphocyte epitope and its agonist epitope from the non-variable number of muc-1 tandem repeat sequences
|
EP1702069A2
(en)
*
|
2004-01-05 |
2006-09-20 |
EMD Lexigen Research Center Corp. |
Interleukin-12 targeted to oncofoetal fibronectin
|
CN102816241B
(zh)
|
2004-02-09 |
2015-07-22 |
人类基因科学公司 |
清蛋白融合蛋白
|
WO2005087810A2
(en)
*
|
2004-03-08 |
2005-09-22 |
Zymogenetics, Inc. |
Dimeric fusion proteins and materials and methods for producing them
|
US20090249503A1
(en)
*
|
2004-12-06 |
2009-10-01 |
Bolder Biotechnology, Inc. |
Enzyme conjugates for use as detoxifying agents
|
TW200722518A
(en)
*
|
2005-03-31 |
2007-06-16 |
Chugai Pharmaceutical Co Ltd |
Sc(fv)2 structural isomers
|
US7482124B2
(en)
*
|
2005-07-08 |
2009-01-27 |
Bristol-Myers Squibb Company |
Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema
|
US20070202512A1
(en)
*
|
2005-08-19 |
2007-08-30 |
Bristol-Myers Squibb Company |
Human single nucleotide polymorphisms associated with dose-dependent weight gain and methods of use thereof
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
CN101351213B
(zh)
|
2005-09-07 |
2013-10-02 |
詹纳里克斯公司 |
使用表达gm-csf的痘病毒系统性治疗转移性癌和/或全身散布性癌
|
KR20140077946A
(ko)
|
2005-10-13 |
2014-06-24 |
휴먼 게놈 사이언시즈, 인코포레이티드 |
자가항체 양성 질환 환자의 치료에 유용한 방법 및 조성물
|
EP1777294A1
(en)
*
|
2005-10-20 |
2007-04-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
|
ATE534415T1
(de)
|
2005-12-13 |
2011-12-15 |
Harvard College |
Gerüste zur zelltransplantation
|
PT1966238E
(pt)
*
|
2005-12-30 |
2012-07-31 |
Merck Patent Gmbh |
Uso de hsp70 como um regulador de atividade enzimática
|
US8921050B2
(en)
*
|
2006-03-17 |
2014-12-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of diagnosing renal cell carcinoma
|
GB0611405D0
(en)
|
2006-06-09 |
2006-07-19 |
Univ Belfast |
FKBP-L: A novel inhibitor of angiogenesis
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
US9505823B2
(en)
*
|
2006-08-07 |
2016-11-29 |
TEV A Biopharmaceuticals USA, Inc. |
Albumin-insulin fusion proteins
|
AU2007353773A1
(en)
*
|
2006-12-22 |
2008-11-27 |
Dow Agrosciences Llc |
Plant-made West Nile virus (WNV) vaccines, vectors and plant codon optimized sequences
|
KR20080084528A
(ko)
|
2007-03-15 |
2008-09-19 |
제네렉스 바이오테라퓨틱스 인크. |
종양살상형 백시니아 바이러스 암 치료
|
WO2009002401A2
(en)
|
2007-06-21 |
2008-12-31 |
President And Fellows Of Harvard College |
Scaffolds for cell collection or elimination
|
US9370558B2
(en)
|
2008-02-13 |
2016-06-21 |
President And Fellows Of Harvard College |
Controlled delivery of TLR agonists in structural polymeric devices
|
CN102006891B
(zh)
|
2008-02-13 |
2017-04-26 |
哈佛学院董事会 |
连续的细胞程序化装置
|
EP2664339A3
(en)
|
2008-03-17 |
2013-12-11 |
Universitätsklinikum Münster |
YopM as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions
|
SI3050576T1
(sl)
|
2008-04-29 |
2021-08-31 |
Ascendis Pharma Endocrinology Division A/S |
Spojine pegiliranega rekombinantnega humanega rastnega hormona
|
WO2009146456A1
(en)
*
|
2008-05-30 |
2009-12-03 |
President And Fellows Of Harvard College |
Controlled release of growth factors and signaling molecules for promoting angiogenesis
|
AU2009262199B2
(en)
|
2008-06-27 |
2012-08-09 |
Amgen Inc. |
Ang-2 inhibition to treat multiple sclerosis
|
JP5936112B2
(ja)
|
2009-02-11 |
2016-06-15 |
アルブミディクス アクティーゼルスカブ |
アルブミン変異体及び複合体
|
US9297005B2
(en)
|
2009-04-13 |
2016-03-29 |
President And Fellows Of Harvard College |
Harnessing cell dynamics to engineer materials
|
EP2419010A4
(en)
*
|
2009-04-18 |
2012-12-12 |
Univ Michigan |
TARGETED DETECTION OF DYSPLASIA IN BARRETT SOPHAGE USING A NEW FLUORESCENCE-MARKED POLYPEPTIDE
|
WO2011014871A1
(en)
|
2009-07-31 |
2011-02-03 |
President And Fellows Of Harvard College |
Programming of cells for tolerogenic therapies
|
ES2848650T3
(es)
|
2009-09-14 |
2021-08-11 |
Sillajen Biotherapeutics Inc |
Terapia combinada contra el cáncer con virus vaccinia oncolítico
|
CA2776241A1
(en)
|
2009-10-30 |
2011-05-05 |
Novozymes Biopharma Dk A/S |
Albumin variants
|
MX2012005527A
(es)
|
2009-11-13 |
2012-08-08 |
Grifols Therapeutics Inc |
Preparaciones que contienen el factor de von willebrand (fvw) procedimientos, kits y aplicaciones relacionados con las mismas.
|
MX337432B
(es)
|
2009-12-15 |
2016-03-04 |
Ascendis Pharma As |
Composicion de la hormona del crecimiento seca enlazada transitoriamente a un portador del polimero.
|
WO2011109834A2
(en)
|
2010-03-05 |
2011-09-09 |
President And Fellows Of Harvard College |
Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1
|
WO2011115688A2
(en)
|
2010-03-19 |
2011-09-22 |
H. Lee Moffitt Cancer Center & Research Institute |
Integrin interaction inhibitors for the treatment of cancer
|
JP5628544B2
(ja)
*
|
2010-04-07 |
2014-11-19 |
株式会社豊田中央研究所 |
クロストリジウム・サーモセラム由来のタンパク質複合体を構築するためのタンパク質及びその利用
|
US10233228B2
(en)
|
2010-04-09 |
2019-03-19 |
Albumedix Ltd |
Albumin derivatives and variants
|
US9693954B2
(en)
|
2010-06-25 |
2017-07-04 |
President And Fellows Of Harvard College |
Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones
|
JP6104806B2
(ja)
|
2010-10-06 |
2017-03-29 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
材料に基づく細胞治療のための注射可能孔形成性ハイドロゲル
|
US9603894B2
(en)
|
2010-11-08 |
2017-03-28 |
President And Fellows Of Harvard College |
Materials presenting notch signaling molecules to control cell behavior
|
US9919047B2
(en)
|
2011-01-04 |
2018-03-20 |
Sillajen, Inc. |
Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
|
EP2681245B1
(en)
|
2011-03-03 |
2018-05-09 |
Zymeworks Inc. |
Multivalent heteromultimer scaffold design and constructs
|
US10647959B2
(en)
|
2011-04-27 |
2020-05-12 |
President And Fellows Of Harvard College |
Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation
|
JP6359966B2
(ja)
|
2011-04-28 |
2018-07-18 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
最小侵襲投与のための注射可能な予成形される肉眼的三次元スキャフォールド
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
JP6062426B2
(ja)
|
2011-06-03 |
2017-01-18 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
インサイチュー抗原生成癌ワクチン
|
EP2537933A1
(en)
|
2011-06-24 |
2012-12-26 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
An IL-15 and IL-15Ralpha sushi domain based immunocytokines
|
EP2780364A2
(en)
|
2011-11-18 |
2014-09-24 |
Eleven Biotherapeutics, Inc. |
Proteins with improved half-life and other properties
|
CN104411331B
(zh)
|
2012-01-13 |
2018-08-21 |
哈佛学院董事会 |
在结构聚合装置中tlr激动剂的控制传递
|
CA2861592A1
(en)
|
2012-03-16 |
2013-09-19 |
Novozymes Biopharma Dk A/S |
Albumin variants
|
EP3662896B1
(en)
|
2012-04-16 |
2024-02-28 |
President and Fellows of Harvard College |
Mesoporous silica compositions for modulating immune responses
|
AU2013289881B2
(en)
|
2012-07-13 |
2018-01-18 |
Zymeworks Bc Inc. |
Multivalent heteromultimer scaffold design and constructs
|
CA2890766A1
(en)
|
2012-11-08 |
2014-05-15 |
Novozymes Biopharma Dk A/S |
Albumin variants
|
HUE058364T2
(hu)
|
2013-04-19 |
2022-07-28 |
Cytune Pharma |
Citokinbõl származó kezelés redukált vaszkuláris permeabilitási szindrómával
|
EP2992329A1
(en)
|
2013-05-03 |
2016-03-09 |
Eleven Biotherapeutics, Inc. |
Albumin variants binding to fcrn
|
SI3030575T1
(sl)
|
2013-08-08 |
2018-11-30 |
Cytune Pharma |
Modulokini na osnovi IL-15 in IL-15R-alfa sushi domene
|
PT3030262T
(pt)
|
2013-08-08 |
2019-12-11 |
Inst Gustave Roussy Igr |
Composição farmacêutica de associação
|
CA2924020A1
(en)
|
2013-09-20 |
2015-03-26 |
Westfaelische Wilhelms-Universitaet Muenster |
Cell-penetrating bacterial e3-ubiqitin-ligases for use in immunotherapy
|
EP2915569A1
(en)
|
2014-03-03 |
2015-09-09 |
Cytune Pharma |
IL-15/IL-15Ralpha based conjugates purification method
|
WO2015168379A2
(en)
|
2014-04-30 |
2015-11-05 |
President And Fellows Of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
WO2016123573A1
(en)
|
2015-01-30 |
2016-08-04 |
President And Fellows Of Harvard College |
Peritumoral and intratumoral materials for cancer therapy
|
EP3058956A1
(en)
|
2015-02-23 |
2016-08-24 |
Institut Curie |
Combined vaccination/radioterapy for cancer treatment
|
WO2016176573A1
(en)
|
2015-04-30 |
2016-11-03 |
Board Of Regents, The University Of Texas System |
Antibacterial polypeptide libraries and methods for screening the same
|
EP3310383B1
(en)
|
2015-06-19 |
2020-02-19 |
Sillajen, Inc. |
Compositions and methods for viral embolization
|
BR112018003179A2
(pt)
|
2015-08-20 |
2018-09-25 |
Albumedix As |
conjugados e variantes de albumina
|
US10858452B2
(en)
|
2015-09-16 |
2020-12-08 |
Insitut National de la Sante et de la Recherche Medicale (INSERM) |
Specific interleukin-15 (IL-15) antagonist polypeptide and uses thereof for the treatment of inflammatory and auto-immune diseases
|
EA201891287A1
(ru)
|
2015-12-04 |
2018-11-30 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Вакцинация с использованием альфа 3-домена mica/b для лечения рака
|
WO2020148206A1
(en)
|
2019-01-14 |
2020-07-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and kits for generating and selecting a variant of a binding protein with increased binding affinity and/or specificity
|
WO2022101463A1
(en)
|
2020-11-16 |
2022-05-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of the last c-terminal residues m31/41 of zikv m ectodomain for triggering apoptotic cell death
|